According to PANews, Helius Medical Technologies, listed on NASDAQ as HSDT, has received board approval to rebrand as Solana Company, while retaining its stock symbol. The company has signed a non-binding letter of intent with the Solana Foundation, committing to the 'Solana By Design' initiative. This includes conducting all on-chain activities exclusively on Solana, co-hosting events, and collaborating with institutions. Additionally, the agreement allows for discounted purchases of SOL when certain conditions are met. The company continues its digital asset treasury strategy, utilizing recent $500 million PIPE financing to accumulate SOL and generate on-chain revenue.